Drug · DIN 02483017
REDDY-LENALIDOMIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 1, 2021; first marketed September 1, 2021.
- Drug Identification Number (DIN)
- 02483017
- Company (DIN owner)
- Dr Reddy's Laboratories LtdPrinceton, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lenalidomide L04AX04
- Class
- Human
- Record last updated
- July 24, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LENALIDOMIDE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2021: NOC 26556Abbreviated New Drug Submission (ANDS)
Other DINs named REDDY-LENALIDOMIDE
- DIN 02483025 · Marketed
- DIN 02483033 · Marketed
- DIN 02483041 · Marketed
- DIN 02483068 · Marketed
- DIN 02484714 · Marketed